Johnson & Johnson, P&G Quarterly Earnings Beat on Top, Bottom Lines

Johnson & Johnson and P&G each reported earnings results this morning. Both companies beat on earnings and revenue for the latest quarter. Johnson & Johnson also revealed $100 million in sales of its coronavirus vaccine in Q1 alone, after saying previously the vaccine will be made available on a not-for-profit basis until the pandemic ends.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.